GnRH agonist and hCG (dual trigger) versus hCG trigger for follicular maturation: a systematic review and meta-analysis of randomized trials

被引：0
|
作者：
Kai-Lun Hu
Siwen Wang
Xiaohang Ye
Dan Zhang
Sarah Hunt
机构：
[1] Zhejiang University,Key Laboratory of Reproductive Genetics (Ministry of Education) and Department of Reproductive Endocrinology, Women’s Hospital, School of Medicine
[2] Key Laboratory of Women’s Reproductive Health of Zhejiang Province,Department of Obstetrics and Gynaecology
[3] Monash University,undefined
来源：
Reproductive Biology and Endocrinology | / 19卷
关键词：
GnRH agonist; hCG; Dual trigger; Randomized trial; Systematic review; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] RCT of Dual-Triger (GnRH-Agonist & hCG) versus hCG-Trigger alone for Normal Responders in IVF-ICSI Cycles
    Singh, M.
    HUMAN REPRODUCTION, 2022, 37 : I522 - I523
  • [32] THE EFFECT OF LOW DOSE HCG/GNRH AGONIST DUAL-TRIGGER ON PREGNANCY OUTCOMES.
    Shapiro, M.
    Romanski, P.
    Thomas, A. M.
    Farland, L. V.
    Yanushpolsky, E.
    FERTILITY AND STERILITY, 2018, 110 (04) : E338 - E338
  • [33] ANALYSIS OF SPINDLE CHARACTERISTICS AND EMBRYO QUALITY IN ADVANCED-AGE WOMEN TRIGGER WITH GnRH AGONIST AND HCG (DUAL TRIGGER) VERSUS DOUBLE-DOSE (500 μg) HCG USING POLSCOPE IMAGING.
    Lee, Junghyun
    Park, Eun A.
    Ryu, Hyoung-Eun
    Hwang, Sun-Nyoung
    Baek, Ji I.
    Shin, Min Young
    Lee, Seon Hee
    Lee, Youngeun
    Kim, Young Im.
    Kim, You Shin
    FERTILITY AND STERILITY, 2024, 122 (04) : E223 - E224
  • [34] OOCYTE DEVELOPMENTAL POTENTIAL FOLLOWING STANDARD HCG OR COMBINED HCG AND GNRH-AGONIST TRIGGER.
    Pereira, N.
    Shah, N. J.
    Mostisser, C.
    Elias, R.
    Rosenwaks, Z.
    FERTILITY AND STERILITY, 2018, 110 (04) : E308 - E308
  • [35] Dual trigger versus hCG-only trigger in ICSI patients: an analysis of 8500 cycles
    Blockeel, C.
    Agius, M. P.
    De Rijdt, S.
    Tournaye, H.
    De Vos, M.
    Drakopoulos, P.
    HUMAN REPRODUCTION, 2023, 38
  • [36] Dual trigger with gonadotropin-releasing hormone agonist and hCG to improve oocyte maturation rate
    Herbemont, C.
    El Kouhen, I
    Brax, A.
    Vinolas, C.
    Dagher-Hayeck, B.
    Comtet, M.
    Calvo, J.
    Sarandi, S.
    Grynberg, M.
    Cedrin-Durnerin, I
    Sifer, C.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2019, 47 (7-8): : 568 - 573
  • [37] COMPARING THE EFFICACY AND SAFETY OF GnRH AGONIST (LEUPROLIDE) WITH HCG TRIGGER VERSUS GnRH ANTAGONIST (GANIRELIX) WITH TRIPTORELIN TRIGGER IN PATIENTS OF PCOD UNDERGOING IVF TREATMENT
    Sharma, R.
    Rehman, F.
    Nakshtramalini, N.
    FERTILITY AND STERILITY, 2013, 100 (03) : S109 - S109
  • [38] GnRH agonist in association with hCG versus hCG alone for final oocyte maturation triggering in GnRH antagonist cycles
    de Oliveira Filho, Condesmar M.
    de Oliveira, Carlos A. M.
    Fonseca, Larissa L.
    de Souza, Kelly R. R.
    Radaelli, Moacir R. M.
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2021, 25 (02): : 246 - 251
  • [39] COMPARISON OF REPRODUCTIVE OUTCOMES BETWEEN TRIGGER WITH HCG VERSUS GnRH AGONIST IN EGGS DONORS CYCLE.
    Zapata-Loera, M. A.
    Obeso-Montoya, I.
    Santos-Haliscak, R.
    Castillo-Baso, J.
    Patrizio, P.
    Berbey, R.
    FERTILITY AND STERILITY, 2013, 100 (03) : S273 - S273
  • [40] GnRH agonist trigger with intensive luteal phase support versus hCG trigger with standard luteal phase support in a population of high responders
    Christopoulos, G.
    Vlismas, A.
    Carby, A.
    Lavery, S.
    Trew, G.
    HUMAN REPRODUCTION, 2015, 30 : 413 - 414
12345